GSE222758 0 V 2 CLOFAZIMINE HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE222758 0 V 2 CLOFAZIMINE HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE222758 0 V 2 CLOFAZIMINE HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE222758 0 V 2 CLOFAZIMINE HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE222758 0 V 2 CLOFAZIMINE HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

H2A clustered histone 19

Gene

ABCF2-H2BK1 readthrough

Gene

lysine demethylase 4F

Gene

solute carrier family 25 member 25

Gene

Ras association domain family member 8

Gene

ATPase H+ transporting V0 subunit d2

Gene

ADP-ribosylhydrolase like 1

Gene

FKBP prolyl isomerase family member 15

Gene

RNA polymerase I transcription factor RRN3

Gene

SREBF pathway regulator in golgi 1

  • Gene

    H2A clustered histone 19


  • Gene

    ABCF2-H2BK1 readthrough


  • Gene

    lysine demethylase 4F


  • Gene

    solute carrier family 25 member 25


  • Gene

    Ras association domain family member 8


  • Gene

    ATPase H+ transporting V0 subunit d2


  • Gene

    ADP-ribosylhydrolase like 1


  • Gene

    FKBP prolyl isomerase family member 15


  • Gene

    RNA polymerase I transcription factor RRN3


  • Gene

    SREBF pathway regulator in golgi 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.